Summary
- Current Price
- As of today, IFRX price is $0.94, down -7.84% on
- Current Price All-Time High
- IFRX price is currently -98.23% below its historical high of $53.10 set on
- Market Cap
- IFRX current market cap is $64M, down -28.68% year-over-year
- PE Ratio
- IFRX PE ratio is unknown
- Revenue
- IFRX current annual revenue is $33.10K, down -81.54% year-over-year
- Next Earnings
- The next earnings release for IFRX is on
Profile
| Metric | Value |
|---|---|
| Full Name | InflaRx N.V. |
| Ticker | NASDAQ: IFRX |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | Germany |
| IPO | |
| Indexes | Not included |
| Website | inflarx.de |
| Employees | 74 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $0.94 | ||
| Price, 1D Change | -7.84% | |
| $64M | ||
| - | ||
| - | ||
| 1.14 | ||
| $33K | ||
| Revenue, 1Y Change | -81.54% | |
| -$0.77 | ||
| EPS, 1Y Change | +9.50% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$0.77 | ||
| EPS Estimate | N/A | -$0.69 |
| EPS Est. Change | N/A | +9.52% |
| $33.10K | ||
| Revenue Estimate | N/A | - |
| Revenue Est. Change | N/A | - |
| $0.94 | ||
| Price Target | - | - |
| Price Tgt. Change | - | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.98 | -$0.85 | +13.70% | |
| -$0.68 | -$0.77 | -12.56% | |
| -$0.69 | N/A | +9.52% | |
| -$0.68 | N/A | +11.68% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $283.25K | $179.30K | -36.70% | |
| $73.83K | $33.10K | -55.17% | |
| - | N/A | - | |
| $69.25K | N/A | +109.21% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| -29.32% | ||
| -47.78% | ||
| -28.68% | ||
| -20.86% | ||
| -81.54% | ||
| +100.00% | ||
| +9.50% | ||
| -9.20% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| $0.94 | ||
| $1.07 | ||
| SMA 200 vs Price | +13.63% | |
| $0.93 | ||
| SMA 50 vs Price | -1.47% | |
| 1.14 | ||
| $0.08 | ||
| 50.65 | ||
| 68.14% | ||
| 118.16% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $33.10K | ||
| -$0.77 | ||
| -$8.64M | ||
| -26.11% | ||
| -$57.46M | ||
| -173.60% | ||
| -$51.50M | ||
| -155.59% | ||
| -$56.99M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.02 | ||
| 4.13 | ||
| 4.13 | ||
| - | ||
| 2 | ||
| -9.24 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 878.38 | ||
| 1.19 | ||
| -0.30 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $48.81M | ||
| $54.56M | ||
| $64.85M | ||
| $62.99M | ||
| $16.04M | ||
| $15.25M | ||
| $1.05M | ||
| $301.80K | ||
| $6.34M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $51.53M | ||
| $48.82M | ||
| $8.68M | ||
| $20.27M | ||
| $473.40K | ||
| $0.00 | ||
| -$13.90K |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$39.86M | ||
| $3.65M | ||
| $37.60M | ||
| $130.60K | ||
| -$39.99M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Guggenheim | → | |
| HC Wainwright & Co. | → | |
| Leerink Partners | → | |
| Guggenheim | → | |
| Oppenheimer | → | |
| Oppenheimer | ||
| Cantor Fitzgerald | ||
| Guggenheim | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → |
Analyst sentiment
Institutional ownership
Screeners with IFRX
FAQ
What is the ticker symbol for InflaRx N.V.?
The ticker symbol for InflaRx N.V. is NASDAQ:IFRX
Does InflaRx N.V. pay dividends?
No, InflaRx N.V. does not pay dividends
What sector is InflaRx N.V. in?
InflaRx N.V. is in the Healthcare sector
What industry is InflaRx N.V. in?
InflaRx N.V. is in the Biotechnology industry
What country is InflaRx N.V. based in?
InflaRx N.V. is headquartered in Germany
When did InflaRx N.V. go public?
InflaRx N.V. initial public offering (IPO) was on November 7, 2017
Is InflaRx N.V. in the S&P 500?
No, InflaRx N.V. is not included in the S&P 500 index
Is InflaRx N.V. in the NASDAQ 100?
No, InflaRx N.V. is not included in the NASDAQ 100 index
Is InflaRx N.V. in the Dow Jones?
No, InflaRx N.V. is not included in the Dow Jones index
When was InflaRx N.V. last earnings report?
InflaRx N.V.'s most recent earnings report was on November 10, 2025
When does InflaRx N.V. report earnings?
The next expected earnings date for InflaRx N.V. is May 6, 2026
Data Sources & References
- IFRX Official Website www.inflarx.de
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1708688/000114036125041266/0001140361-25-041266-index.htm
- IFRX Profile on Yahoo Finance finance.yahoo.com/quote/IFRX
- IFRX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/ifrx